Compass Therapeutics, Inc. (CMPX)

CIK 1738021 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Compass Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Oct 2, 202640001171843-26-006349
Sep 25, 202640001171843-26-006235
Sep 22, 20268-K0001171843-26-006162
Aug 14, 2026SCHEDULE 13G/A0001213900-26-089989
Aug 7, 2026SCHEDULE 13G0000093751-26-000440
Aug 6, 20268-K0001171843-26-005292
Aug 6, 202610-Q0001171843-26-005295
Jul 1, 20268-K0001171843-26-004428
Jun 23, 20268-K0001171843-26-004224
Jun 11, 20268-K0001171843-26-004068
May 15, 2026SCHEDULE 13G/A0000921895-26-001388
May 5, 202610-Q0001171843-26-003006
May 5, 20268-K0001171843-26-003005
Apr 30, 20264/A0001171843-26-002893
Apr 30, 20264/A0001171843-26-002894
Apr 29, 202640001171843-26-002840
Apr 29, 2026ARS0001140361-26-017651
Apr 29, 2026DEFA14A0001140361-26-017650
Apr 29, 202640001171843-26-002834
Apr 29, 2026DEF 14A0001140361-26-017649
Apr 27, 20268-K0001171843-26-002720
Mar 12, 2026S-80001193125-26-103115
Mar 5, 20268-K0001171843-26-001336
Mar 5, 202610-K0001171843-26-001337
Feb 13, 2026SCHEDULE 13G/A0001193125-26-051513